To understand why TRAIL was suppressed in CAD, we found that elevated levels of IL-18 repressed TRAIL transcription and gene expression in healthy human monocytes by inhibiting NFκB’s ability to bind the TRAIL promoter [23]. This evidence concerns the gene IL18 and coronary artery disorder.